Mode
Text Size
Log in / Sign up

Systematic review finds shockwave therapy offers no consistent benefit for Achilles tendinopathy compared to controlsShockwave Therapy Fails for Achilles Pain Relief

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider prioritizing alternative treatments over shockwave therapy for Achilles tendinopathy given low-certainty evidence of benefit.

This systematic review with meta-analysis examines the efficacy of shockwave therapy for insertional and midportion Achilles tendinopathy in adults. The review included 557 participants and compared radial or focused SWT with or without co-interventions against sham-SWT, no treatment, or wait-and-see controls. Follow-up assessments covered short- and long-term outcomes.

The analysis found no clinically meaningful benefit over sham for insertional Achilles tendinopathy. For midportion Achilles tendinopathy, there were no significant differences in disability or pain between SWT and control interventions at all timepoints. However, one trial did report a benefit over sham-SWT for midportion cases. The evidence for radial SWT in midportion cases showed very low-certainty evidence of a clinically meaningful effect on improvements in disability and pain compared to sham or wait-and-see controls.

Safety concerns were noted as two Achilles tendon ruptures were reported following focused SWT. Most effect estimates are based on very low- and low-certainty data. One trial did not report success of participant blinding. The authors state that true effects may change with future high-quality trials.

The review concludes that SWT should not be considered a routine treatment for either insertional or midportion Achilles tendinopathy, and alternative treatments should be prioritized.

The promise was too good to be true

For years, shockwave therapy was seen as a hopeful fix. The idea was simple. Send sound waves into damaged tissue. That energy should spark healing. Reduce pain. Get people moving again.

Clinics offered it. Insurance sometimes covered it. Patients paid out of pocket, hoping for results.

But here’s the problem. Hope isn’t proof.

And now, a major review of the best available science says the proof just isn’t there.

No real gain for heel pain

The review looked at nine high-quality trials. These studies followed 557 adults with either midportion or insertional Achilles tendinopathy. Some got real shockwave therapy. Others got fake treatment or nothing at all.

The results were clear. For both types of tendon pain, shockwave therapy did not lead to meaningful improvements in pain or function.

We’re not talking about a small miss. We’re talking about no consistent benefit across any time frame. Not at four weeks. Not at six months. Not at one year.

One trial did show a benefit. But it had a big flaw. Researchers didn’t confirm whether patients knew they were getting the real treatment. That can skew results. When people think they’re being treated, they often report feeling better—even if the treatment does nothing.

Why the hype never matched reality

Think of your tendon like a frayed rope. Overuse, age, or sudden stress weakens the fibers. Inflammation follows. Pain sets in.

Shockwave therapy was supposed to act like a reset button. The pulses would break up scar tissue, boost blood flow, and wake up healing cells.

It made sense in theory. Like jump-starting a stalled engine.

But the body doesn’t always respond like a machine.

The new data suggest the pulses don’t create the biological changes needed. No real repair. No lasting pain drop.

And there’s more.

Two cases of full Achilles tendon rupture were reported after focused shockwave therapy. That’s rare, but serious. A rupture can require surgery and months of rehab.

The evidence is shaky

Most of the data in this review are rated as very low or low certainty. That means future studies could change the results. But right now, the trend is clear.

Neither radial nor focused shockwave therapy showed a clear edge.

Wait-and-see approaches—doing nothing but monitoring—performed about the same.

Physical therapy, load management, and exercise programs still appear more effective.

But there’s a catch.

This doesn't mean this treatment is available yet.

Many clinics still offer shockwave therapy. Some patients swear by it. But this review suggests those gains may come from time, rest, or other treatments—not the shockwaves.

Experts say the findings should make doctors rethink how they treat Achilles pain.

Routine use of shockwave therapy is not supported. The risks may outweigh the benefits.

What this means for patients

If you’re considering shockwave therapy, talk to your doctor. Ask about the latest evidence.

Focus on what works. Gradual strengthening. Eccentric calf exercises. Proper footwear. Activity modification.

These aren’t flashy. But they’re proven.

And they don’t carry the risk of tendon rupture.

Shockwave therapy isn’t banned. It’s still used for other conditions, like kidney stones. But for Achilles pain, its role is fading.

The data need to get stronger

The main weakness? The studies were small. Some had poor blinding. Others used different doses or devices. That makes it hard to compare results.

Future trials need to be larger. Better designed. More consistent in how they deliver treatment.

Until then, the message is straightforward.

Shockwave therapy is not a reliable fix for Achilles tendinopathy.

More research is coming. But for now, the door is closing on this once-promising option.

Patients deserve treatments that work. And the best path forward may be simpler, safer, and already in plain sight.

Study Details

Study typeMeta analysis
Sample sizen = 557
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
To evaluate the effects of shockwave therapy (SWT) for Achilles tendinopathy compared to sham-SWT as a monotherapy or co-intervention or no treatment. Intervention systematic review with meta-analysis of randomized controlled trials (RCTs). AMED, CINAHL, Web of Science, MEDLINE, EMBASE, SPORTDiscus, Cochrane CENTRAL, clinical trial registries, and gray literature were searched between February 14 and February 24, 2025. Criteria included RCTs assessing radial or focused SWT (with or without co-interventions) in adults with Achilles tendinopathy. We conducted a random-effects meta-analysis. We assessed risk of bias using the Cochrane Risk of Bias 2 tool and certainty of evidence using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) framework. Nine RCTs (n = 557) were included. For insertional Achilles tendinopathy, SWT showed no clinically meaningful benefit over sham (low-moderate certainty), with consistent findings across all outcomes and sensitivity/subgroup analyses. For midportion Achilles tendinopathy, all meta-analyses (very low and moderate certainty) showed no significant differences in disability or pain between SWT and control interventions at all timepoints. There was very low-certainty evidence of a clinically meaningful effect of radial SWT on short- and long-term improvements in disability and pain compared to sham or wait-and-see controls. One trial (midportion Achilles tendinopathy) showed benefit over sham-SWT but did not report success of participant blinding. Subgroup analyses revealed no clear advantage for either radial or focused SWT. Two Achilles tendon ruptures were reported following focused SWT. There was no clinically meaningful benefit of SWT in pain and disability for Achilles tendinopathy, with evidence ranging from very low to moderate certainty. Because most effect estimates are based on very low- and low-certainty data, the true effects may change with future high-quality trials. At present, SWT should not be considered a routine treatment for either insertional or midportion Achilles tendinopathy, and alternative treatments should be prioritized. .
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.